Drug composition and preparation process. Requirement 1: it consists of formula (1),Among them, R1,Each substance is the same o r different, selected from the halogen group, R, o r, NRR, CN, cf8323,C (O) R C (O) OR C (O) NRR NOC₁₋₆-OR alkylene, C₁₋₆-NRR alkylene, C₁₋₆-CO₂R alkylene, C₁₋₆-C (O) alkylene NRR, -O-C₁₋₆-CO₂R alkylene, -O-C₁₋₆-alkylene C (O) NRR, CO₂-alkylene C₁₋₆-OR, CO₂-alkylene C₁₋₆-NRR, C (O) NH-alkylene C₁₋₆-OR, C (O) NH-alkylene C₁₋₆-NRR, OCF₃,SO R SO H SO NRR NHSO R R C CR(R) (R) C 3DC (R)C₁₋₆-C (O) R alkylene, NHC (O) R, or C₁₋₆ alkyl,interrupted by at least one heteroatom, preferably chosen from O, N or S, preferably O； L¹ is linear or branched C₁₋₆ alkylene optionally substituted by one or more of = O, CN, C (O) R, C (O) OR or C (O) NRR, or CH₂-linear or branched C₁₋₆ alkylene , in which the subsequent C₁₋₆ alkylene is optionally substituted by one or more of halogen, OR, NRR or CF₃；Q is 0, 1, 2, 3 or 4； X is cr8311831；R⁷ is OR, halogen, linear or branched C₁₋₆-OR alkyl, C (O) OR, C (O) NRR, CN, OR⁹,NR SR； n is 0, 1 or 2； P is 1, 2 or 3； R 3,R830808,R831222 and r831222,each one is identical or different, they are chosen from the group consisting of H, linear or branched C₁₋₆-alkyl, halogen, OH, -O-Cilo-alkyl,NRR CN CFo. C (o) r, C (o) or C (o) NR； a was selected from the following groups:-C (O) NH--SO₂-；or -SO₂N-；L² is linear or branched C₁₋₆-O alkylene or linear or branched C₁₋₆ alkylene, optionally interrupted by at least one heteroatom chosen from O, NR or S and / or optionally substituted by: R, OR, NRR, alkyl C₁₋₆-OR C₁₋₆-NRR alkyl, OC (O) R, NHC (O) R, NHC (O) NRR, CN, C (= NH) NHOR； R⁶ is chosen from the group consisting of aryl, heteroaryl, cycloalkyl, heterocycle, H, in which the aryl, heteroaryl, cycloalkyl or heterocycle is mono or polycyclic and is optionally substituted by one or more linear or branched C₁₋₆ alkyl, halogen, NRR, CN, CF₃,OR, = O, C (O) R, C (O) OR, NHC (O) R, OC (O) R, linear or branched Cque alkenylene or CONRR； eac
